Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1193, 2008-01, pp. : 21-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab: Tumour lysis syndrome (first report) in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1190, 2008-01 ,pp. :
Cetuximab: Fatal tumour lysis syndrome (first report): case report
Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. :
LBH-589: First report of tumour lysis syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. :
Bortezomib: Tumour lysis syndrome (first report) in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. :
Paclitaxel: Tumour lysis syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :